ABG-WTT Global Life Science Capital Partners GP

Latest statistics and disclosures from ABG-WTT Global Life Science Capital Partners GP's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CGON, RPID, LUNG, and represent 100.00% of ABG-WTT Global Life Science Capital Partners GP's stock portfolio.
  • Added to shares of these 1 stock: CGON (+$40M).
  • Started 1 new stock position in CGON.
  • Reduced shares in these 2 stocks: Rayzebio (-$48M), MDVLQ.
  • Sold out of its positions in MDVLQ, Rayzebio.
  • ABG-WTT Global Life Science Capital Partners GP was a net seller of stock by $-9.6M.
  • ABG-WTT Global Life Science Capital Partners GP has $42M in assets under management (AUM), dropping by -19.09%.
  • Central Index Key (CIK): 0001832108

Tip: Access up to 7 years of quarterly data

Positions held by ABG-WTT Global Life Science Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for ABG-WTT Global Life Science Capital Partners GP

ABG-WTT Global Life Science Capital Partners GP holds 3 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cg Oncology (CGON) 96.8 $40M NEW 916k 43.90
 View chart
Rapid Micro Biosystems Class A Com (RPID) 1.9 $768k 1.0M 0.74
 View chart
Pulmonx Corp (LUNG) 1.3 $558k 60k 9.27
 View chart

Past Filings by ABG-WTT Global Life Science Capital Partners GP

SEC 13F filings are viewable for ABG-WTT Global Life Science Capital Partners GP going back to 2020